The peptide suppresses pro-inflammatory cytokines including TNF-, IL-6, and TGF-, which are key drivers of chronic low-grade inflammation (inflammaging) in older skin
While the current GLP-1 drug MDL, established in the Eastern District of Pennsylvania, is focused on gastrointestinal injuries, the surge in NAION-related cases is raising the question of whether the scope of that MDL will be expanded to include additional categories of injury
PMID: 211 TesarikJConde-LpezCGaln-LzaroMMendoza-TesarikR
Katie, Senior Manager of Scientific Affairs at Kyowa Hakko, discusses the latest studies examining this powerful combination, including newly discovered mechanisms and applications in sports nutrition
Clinically Proven Safety Profile 1) Advantages: - Supported by clinical studies demonstrating low irritation (ideal for post-procedure skin)